HDL-targeted therapies: progress, failures and future

Kingwell, Bronwyn A., Chapman, M. John, Kontush, Anatol, Miller, Norman E.·2014·Nature Reviews Drug Discovery

DOI 10.1038/nrd4279

Cited by (355)

Items 101–200 of 355

Plasminogen promotes cholesterol efflux by the ABCA1 pathway
Nathalie Pamir, Patrick M. Hutchins, Graziella E. Ronsein, Wei Hao, Chongren Tang, Riku Das, Tomáš Vaisar, Edward F. Plow, Volker H. Schuster, Marlys L. Koschinsky et al. · 2017 · JCI Insight
Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol
Kelly A. Manthei, Shyh‐Ming Yang, Bolormaa Baljinnyam, Louise C. Chang, Alisa Glukhova, Wenmin Yuan, Lita A. Freeman, David J. Maloney, Anna A. Schwendeman, Alan Thomas Remaley et al. · 2018 · eLife
Niacin as antidyslipidemic drug
Ulrich Julius · 2015 · Canadian Journal of Physiology and Pharmacology
Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis
Dong Zhao, Haozhe Shi, Mingming Zhao, Xin Zhang, Wei Y. Huang, Yuhui Wang, Lemin Zheng, Xunde Xian, Chaojie Liu · 2018 · Metabolism
The pleiotropic vasoprotective functions of high density lipoproteins (HDL)
Guilaine K. Boyce, Emily B. Button, S.V. Sonja, Cheryl Lea Wellington · 2017 · Journal of Biomedical Research
Anti-diabesity middle eastern medicinal plants and their action mechanisms
Saad, Bashar, Kmail, Abdalsalam, Haq, Sameena Z. H. · 2022 · Evidence-Based Complementary and Alternative Medicine
High-Density Lipoproteins: A Role in Inflammation in COPD
Stanislav Nikolaevich Kotlyarov · 2022 · International Journal of Molecular Sciences
Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
Eftaxia-Konstantina Valanti, Katerina Dalakoura-Karagkouni, Despina Sanoudou · 2018 · Journal of Personalized Medicine
Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study
Evgenia Gourgari, Martin Peter Playford, Umberto Campia, Amit Kumar Dey, Fran R. Cogen, Stephanie Gubb-Weiser, Mihriye Méte, Sameer Y. Desale, Maureen L. Sampson, Allen J. Taylor et al. · 2018 · Cardiovascular Diabetology
TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis
Nicole J. Lake, Rachael L Taylor, Hugh Trahair, Harikrishnan Kaipananickal, Joanne E. Curran, Marcio Almeida, Hemant R. Kulkarni, Nigora Mukhamedova, Anh Hoang, Hann Low et al. · 2017 · European Heart Journal
The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
Dustin Chernick, Rui Zhong, Ling Li · 2020 · Biomolecules
Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis
Hala Hussein, Samir Saheb, Martine Couturier, Marielle Atassi, Alexina Orsoni, Alain Carrié, Patrice Thérond, Sandrine Chantepie, Paul Robillard, Éric Bruckert et al. · 2015 · Journal of clinical lipidology
Reconstituted High-Density Lipoprotein Attenuates Cholesterol Crystal–Induced Inflammatory Responses by Reducing Complement Activation
Nathalie Niyonzima, Eivind Ottersen Samstad, Marie H Aune, Liv Ryan, Siril Skaret Bakke, Anne Mari Rokstad, Samuel D. Wright, Jan Kristian Damås, Tom Eirik Mollnes, Eicke Latz et al. · 2015 · The Journal of Immunology
Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: “Herniated” HDL, a common feature in diabetes
Núria Amigó, Roger Mallol, Mercedes Heras, Sergio Martínez‐Hervás, Francisco Blanco‐Vaca, Joan Carles Escolá‐Gil, Núria Plana, Óscar Yanes, L. Masana, Xavier Correig · 2016 · Scientific Reports
CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet
Lin Zhu, Thao N. Luu, Christopher H. Emfinger, Bryan A. Parks, Jeanne Shi, Elijah Trefts, Fenghua Zeng, Zsuzsanna Kuklenyik, Raymond Clement Harris, David H. Wasserman et al. · 2018 · Diabetes
Roles of Reconstituted High-Density Lipoprotein Nanoparticles in Cardiovascular Disease: A New Paradigm for Drug Discovery
Jiansheng Huang, Dongdong Wang, Li‐Hao Huang, Hui Huang · 2020 · International Journal of Molecular Sciences
Molecular dynamics simulations of lipid nanodiscs
Mohsen Pourmousa, Richard W. Pastor · 2018 · Biochimica et Biophysica Acta (BBA) - Biomembranes
Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly
Hiren Patel, Bei Ding, Kelsey Ernst, Lei Shen, Wenmin Yuan, Jie Tang, Lindsey R. Drake, Jukyung Kang, Yaoxin Li, Zhan Chen et al. · 2019 · International Journal of Nanomedicine
Aggregation Susceptibility of Low-Density Lipoproteins—A Novel Modifiable Biomarker of Cardiovascular Risk
Katariina Öörni, Petri T. Kovanen · 2021 · Journal of Clinical Medicine
A Review of the Anti-Obesity Effects of Wild Edible Plants in the Mediterranean Diet and Their Active Compounds: From Traditional Uses to Action Mechanisms and Therapeutic Targets
Bashar Saad · 2023 · International Journal of Molecular Sciences
Increased atherosclerosis in P2Y13/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transport
Laeticia Lichtenstein, Nizar Serhan, Sara Espinosa Delgado, Aurélie Fabre, Wijtske Annema, Uwe J.F. Tietge, Bernard Robaye, Jean‐Marie Boeynaems, Muriel Laffargue, Bertrand Perret et al. · 2015 · Cardiovascular Research
Does high-density lipoprotein protect vascular function in healthy pregnancy?
Wan N. Wan Sulaiman, MURIEL J. CASLAKE, Christian Delles, Helén Karlsson, Monique T Mulder, Delyth Graham, Dilys J. Freeman · 2016 · Clinical Science
Phosphatidylserine enhances anti‐inflammatory effects of reconstituted HDL in macrophages via distinct intracellular pathways
Maryam Darabi, Marie Lhomme, Veronica D. Dahik, Isabelle Guillas, Éric Frisdal, Emilie Tubeuf, Lucie Poupel, Mili Patel, Emmanuel L. Gautier, Thierry Huby et al. · 2022 · The FASEB Journal
Translating GWAS Findings to Novel Therapeutic Targets for Coronary Artery Disease
Le Shu, Montgomery Blencowe, Xia Yang · 2018 · Frontiers in Cardiovascular Medicine
Scavenging Reactive Lipids to Prevent Oxidative Injury
Linda Zhang, Annet Kirabo, Jiansheng Huang, MacRae F. Linton, Sean S. Davies, Katherine T. Murray · 2020 · The Annual Review of Pharmacology and Toxicology
Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease
Zhiwen Xiao, Zhongqiu Lin, Lin Xu, Wenlong Xu, Haoxiang Huang, Yuegang Wang, Shiping Cao, Zhiquan Xie, Wangjun Liao, Yulin Liao et al. · 2023 · European Journal of Preventive Cardiology
Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis
Lauriane Galle-Treger, Martine Moreau, Raphaëlle Ballaire, Lucie Poupel, Thomas Huby, Emanuele Sasso, Fulvia Troise, Francesco Potì, Philippe Lesnik, Wilfried Le Goff et al. · 2019 · Cardiovascular Research
Deciphering structural aspects of reverse cholesterol transport: mapping the knowns and unknowns
Sukriti Sacher, A.K. Mukherjee, Arjun Ray · 2023 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL
Hagai Tavori, Yan Ru Su, Patricia G. Yancey, Ilaria Giunzioni, Ashley J. Wilhelm, John L. Blakemore, Manal Zabalawi, MacRae F. Linton, Mary G. Sorci‐Thomas, Sergio Fazio · 2015 · Journal of Lipid Research
Re-evaluation of cholesteryl ester transfer protein function in atherosclerosis based upon genetics and pharmacological manipulation
Shizuya Yamashita, Yūji Matsuzawa · 2016 · Current Opinion in Lipidology
The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review
Roosmarijn F.H. Lemmers, Mandy van Hoek, Aloysius G. Lieverse, Adrie J.M. Verhoeven, Eric J.G. Sijbrands, Monique T Mulder · 2017 · Journal of clinical lipidology
Long‐Term Supplementation of Black Elderberries Promotes Hyperlipidemia, but Reduces Liver Inflammation and Improves HDL Function and Atherosclerotic Plaque Stability in Apolipoprotein E‐Knockout Mice
Courtney L. Millar, Gregory H. Norris, Christina Jiang, James Kry, Addison Vitols, Chelsea Garcia, Young‐Ki Park, Ji‐Young Lee, Christopher N. Blesso · 2018 · Molecular Nutrition & Food Research
Effect of the ABCA1 agonist CS-6253 on amyloid-β and lipoprotein metabolism in cynomolgus monkeys
Sasan D. Noveir, Bilal E. Kerman, Haotian Xian, Cristiana Joy Meuret, Sabrina Smadi, Ashley E. Martinez, Johannes Johansson, Henrik Zetterberg, Bryan A. Parks, Zsuzsanna Kuklenyik et al. · 2022 · Alzheimer s Research & Therapy
Nanodiscs: Game changer nano-therapeutics and structural biology tools
Ahmed O. Elzoghby, Omar Samir, Ahmed Soliman, Sergey O. Solomevich, Minzhi Yu, Anna A. Schwendeman, Mahmoud Lotfi Nasr · 2023 · Nano Today
HDL-C vs HDL-P: How Changing One Letter Could Make a Difference in Understanding the Role of High-Density Lipoprotein in Disease
William Sean Davidson · 2014 · Clinical Chemistry
Agonistic Human Antibodies Binding to Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism
Ruwanthi N. Gunawardane, Preston Fordstrom, Derek E. Piper, Stephanie K. Masterman, Sophia Siu, Dongming Liu, M Ichael S. Brown, Mei Ping Lu, Jie Ting Tang, Richard Zhang et al. · 2015 · Journal of Biological Chemistry
Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk: A community-based cohort study
Yue Qi, Jing Liu, Wei Wang, Miao Wang, Fan Zhao, Jiayi Sun, Jun Liu, Dong Hui Zhao · 2017 · Journal of clinical lipidology
Potential Contribution of Short Chain Fatty Acids to Hepatic Apolipoprotein A-I Production
Herman E. Popeijus, Willem Zwaan, Jehad Zuhair Tayyeb, Jogchum Plat · 2021 · International Journal of Molecular Sciences
Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy
Hui Chang, Jiawang Wei, Kai Chen, Shu Zhang, Fei Han, Lixia Lu, Weiwei Xiao, Yuanhong Gao · 2018 · Journal of Cancer
Antibody Targeted PET Imaging of 64 Cu-DOTA-Anti-CEA PEGylated Lipid Nanodiscs in CEA Positive Tumors
Patty W. Wong, Lin Li, Junie Chea, Weidong Hu, Erasmus Kofi Poku, Todd Ebner, Nicole Bowles, Jeffrey Y.C. Wong, Paul J. Yazaki, Stephen G. Sligar et al. · 2020 · Bioconjugate Chemistry
Oxidative modification of HDL by lipid aldehydes impacts HDL function
Reza Fadaei, Sean S. Davies · 2022 · Archives of Biochemistry and Biophysics
Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner
Kristina K. Durham, George Eduardo Gabriel Kluck, Kei Cheng Mak, Yak D. Deng, Bernardo L. Trigatti · 2019 · American Journal of Physiology-Heart and Circulatory Physiology
Serum levels of small HDL particles are negatively correlated with death or lung transplantation in an observational study of idiopathic pulmonary fibrosis
Amisha V. Barochia, Maryann M. Kaler, Nargues A. Weir, Elizabeth M. Gordon, Debbie M Figueroa, Xianglan Yao, Merte Lemma Woldehanna, Maureen L. Sampson, Alan Thomas Remaley, Geraldine M. Grant et al. · 2021 · European Respiratory Journal
Reconstituted HDL as a therapeutic delivery device
Colin A. Fox, Anthony Moschetti, Robert O. Ryan · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Circulating ANGPTL8/Betatrophin Concentrations Are Increased After Surgically Induced Weight Loss, but Not After Diet-Induced Weight Loss
Eider Pascual Corrales, Javier Gómez‐Ambrosi, Rafael Moncada, Víctor Valentí, Victoria Catalán, Amaia Rodrı́guez, Beatriz Ramírez, Camilo Silva, Marı́a J. Gil, Javier Salvador et al. · 2016 · Obesity Surgery
FACEing reality: productive tensions between our epidemiological questions, methods and mission
Nancy Krieger, George Davey Smith · 2016 · International Journal of Epidemiology
Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases
Mark L. Schultz, Maria V. Fawaz, Ruth D. Azaria, Todd Charles Hollon, Elaine A. Liu, Thaddeus J. Kunkel, Troy A. Halseth, Kelsey L. Krus, Ran Ming, Emily E. Morin et al. · 2019 · BMC Medicine
Dissecting the proteome of lipoproteins: New biomarkers for cardiovascular diseases?
Anne von Zychlinski, Torsten Kleffmann · 2015 · Translational Proteomics
FR171456 is a specific inhibitor of mammalian NSDHL and yeast Erg26p
Stephen B. Helliwell, Shantanu Karkare, Marc Bergdoll, Alain Rahier, Juliet R. Leighton-Davis, Céline Fioretto, Thomas Aust, Ireos Filipuzzi, Mathias Ugelstad Frederiksen, John Gounarides et al. · 2015 · Nature Communications
Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics
Dan Li, Maria V. Fawaz, Emily E. Morin, Ran Ming, Denis O. Sviridov, Jie Tang, Rose Ackermann, Karl F. Olsen, Alan Thomas Remaley, Anna A. Schwendeman · 2017 · Molecular Pharmaceutics
The Search for Dietary Supplements to Elevate or Activate Circulating Paraoxonases
José Manuel Lou-Bonafonte, Clara Gabás‐Rivera, María Á. Navarro, Jesús Osada · 2017 · International Journal of Molecular Sciences
High-Density Lipoprotein Modifications: Causes and Functional Consequences in Type 2 Diabetes Mellitus
Xiaodi Zhang, Emiel P. C. van der Vorst · 2024 · Cells
A systematic review of the biodistribution of biomimetic high-density lipoproteins in mice
Dennis Pedersbæk, Jens B. Simonsen · 2020 · Journal of Controlled Release
Exploring the therapeutic potential of the bioinspired reconstituted high density lipoprotein nanostructures
Aditya Gupta, Reena Sharma, Kaushik Kuche, Sanyog Jain · 2021 · International Journal of Pharmaceutics
The A’s Have It
Xianglan Yao, Elizabeth M. Gordon, Amisha V. Barochia, Alan Thomas Remaley, Stewart J. Levine · 2016 · CHEST Journal
Lipid‐Free Apolipoprotein A‐I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio
Sushma Kaul, Hao Xu, Manal Zabalawi, Elisa C Maruko, Brian E. Fulp, Theresa Bluemn, Kristina L. Brzoza‐Lewis, Mark Gerelus, Ranjuna Weerasekera, Rachel Kallinger et al. · 2016 · Journal of the American Heart Association
Effects of Freeze-Dried Grape Powder on High-Density Lipoprotein Function in Adults with Metabolic Syndrome: A Randomized Controlled Pilot Study
Courtney L. Millar, Quinn Duclos, Chelsea Garcia, Gregory H. Norris, Bruno S. Lemos, Diana M DiMarco, María Luz Fernández, Christopher N. Blesso · 2018 · Metabolic Syndrome and Related Disorders
Immune-mediated and lipid-mediated platelet function in atherosclerosis
Maiwand Ahmadsei, Dirk Lievens, Christian Weber, Philipp von Hundelshausen, Norbert Gerdes · 2015 · Current Opinion in Lipidology
CETP inhibitors and cardiovascular disease: Time to think again
N.E. Miller · 2014 · F1000Research
Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction
Serge Korjian, Syed Hassan A. Kazmi, Gerald Chi, Arzu Kalaycı, Jane Lee, Usama Talib, Samuel D. Wright, Danielle Duffy, Bronwyn A. Kingwell, Roxana Mehran et al. · 2023 · European Heart Journal - Cardiovascular Pharmacotherapy
Alterations in high-density lipoprotein proteome and function associated with persistent organic pollutants
Stefan Ljunggren, Ingela Helmfrid, Ulf Norinder, Mats G. Fredriksson, Gun B. Wingren, Helén Karlsson, Mats Lindahl · 2016 · Environment International
Systematic review and meta-analysis deciphering the impact of fibrates on paraoxonase-1 status
Amirhossein Sahebkar, Anna Hernández‐Aguilera, David Abelló, Elena Sancho, Jordi Camps, Jorge Joven · 2016 · Metabolism
Unbiased and targeted mass spectrometry for the HDL proteome
Sasha A. Singh, Masanori Aikawa · 2016 · Current Opinion in Lipidology
Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine
Bianca Scolaro, Marina Sayuri Nogueira, Aline Goulart de Paiva, Adriana Bertolami, Lúcia Pereira Barroso, Tomáš Vaisar, Sean P. Heffron, Edward A A Fisher, Inar Alves de Castro · 2018 · Molecular Metabolism
ApoA-I-Directed Therapies for the Management of Atherosclerosis
John S. Millar, Marina Cuchel · 2015 · Current Atherosclerosis Reports
A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease
Alankrita Rani, Gunther Marsche · 2023 · Pharmaceutics
Association of alpha-aminoadipic acid with cardiometabolic risk factors in healthy and high-risk individuals
Stacy Desine, Curtis L. Gabriel, Holly Smith, Olivia R. Antonetti, Chuan Wang, M. Wade Calcutt, Amanda C. Doran, Heidi J. Silver, Sangeeta Nair, James Greg Terry et al. · 2023 · Frontiers in Endocrinology
Evaluation of HDL-modulating interventions for cardiovascular risk reduction using a systems pharmacology approach
Kapil G. Gadkar, James Jian-Qiang Lu, Srikumar Sahasranaman, John D. Davis, Norman Alan Mazer, Saroja Ramanujan · 2015 · Journal of Lipid Research
Gene-based therapies in lipidology
Daniel Gaudet, Diane Brisson · 2015 · Current Opinion in Lipidology
Fragment-based discovery of novel pentacyclic triterpenoid derivatives as cholesteryl ester transfer protein inhibitors
Yongzhi Chang, Shuxi Zhou, Enqin Li, Wenfeng Zhao, Yanpeng Ji, Xiaoan Wen, Hongbin Sun, Haoliang Yuan · 2016 · European Journal of Medicinal Chemistry
The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease
Eftaxia-Konstantina Valanti, Angeliki Chroni, Despina Sanoudou · 2019 · Current Opinion in Lipidology
Can phosphatidylserine enhance atheroprotective activities of high-density lipoprotein?
Maryam Darabi, Anatol Kontush · 2015 · Biochimie
Novel therapies for severe dyslipidemia originating from human genetics
Daniel Gaudet · 2016 · Current Opinion in Lipidology
Lower or higher HDL-C levels are associated with cardiovascular events in the general population in rural China
Shasha Yu, Xiaofan Guo, Guang Xiao Li, Hongmei Yang, Liqiang Zheng, Yingxian Sun · 2020 · Lipids in Health and Disease
Clusterin, paraoxonase 1, and myeloperoxidase alterations induce high‐density lipoproteins dysfunction and contribute to peripheral artery disease; aggravation by type 2 diabetes mellitus
Gabriela Maria Sanda, Laura Toma, Teodora Barbălată, Oriana E. Moraru, Loredan Stefan Niculescu, Anca Volumnia Sima, Camelia Sorina Stancu · 2021 · BioFactors
Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes
Ying Zhang, Alicia Josephine Jenkins, Arpita Basu, Julie Ann Stoner, Maria Fernanda Lopes-Virella, Richard L. Klein, Timothy J. Lyons · 2015 · Journal of Lipid Research
Nanoengineering Apolipoprotein A1‐Based Immunotherapeutics
David P. Schrijver, Anne de Dreu, Stijn R. J. Hofstraat, Ewelina Kluza, Robby C. Zwolsman, Jeroen Deckers, Tom Anbergen, Koen de Bruin, Mirre M. Trines, Eveline G. Nugraha et al. · 2021 · Advanced Therapeutics
Molecular Dynamics Simulation and Experimental Studies of Gold Nanoparticle Templated HDL-like Nanoparticles for Cholesterol Metabolism Therapeutics
Cheng‐Tsung Lai, Wangqiang Sun, Rohun U Palekar, Colby Shad Thaxton, George Chappell Schatz · 2016 · ACS Applied Materials & Interfaces
High-density lipoproteins from egg yolk's effect on hyperlipidemia in a high-fat-diet obese mouse using lipidomic analysis
Zhihui Yu, Ning Wang, Fang Geng, Meihu Ma · 2019 · Food Bioscience
The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage
C. Roger White, Geeta Datta, Landon Shay Wilson, Mayakonda N. Palgunachari, Gattadahalli M. Anantharamaiah · 2019 · Chemistry and Physics of Lipids
Early Prediction of Left Ventricular Reverse Remodeling in First-Diagnosed Idiopathic Dilated Cardiomyopathy: A Comparison of Linear Model, Random Forest, and Extreme Gradient Boosting
Xiangkun Xie, Mingwei Yang, Shan Xie, Xiaoying Wu, Yuan Jiang, Zhaoyu Liu, Huiying Zhao, Yangxin Chen, Yuling Zhang, Jingfeng Wang · 2021 · Frontiers in Cardiovascular Medicine
U-Shaped Association of High-Density Lipoprotein Cholesterol with All-Cause and Cardiovascular Mortality in Hypertensive Population
Chaolei Chen, Xiaocong Liu, Lin Liu, Kenneth Ka-Hei Lo, Yu‐Ling Yu, Jiayi Huang, Yuqing Huang, Jiyan Chen · 2020 · Risk Management and Healthcare Policy
Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant
Jonathan Dalla‐Riva, Jens O. Lagerstedt, Jitka Petrlová · 2015 · PLoS ONE
High-density lipoprotein 3 cholesterol is a predictive factor for arterial stiffness: a community-based 4.8-year prospective study
Wang, Fan, Wang, Xiaona, Ye, Ping, Cao, Ruihua, Zhang, Yun, Qi, Yue, Zhao, Dong · 2018 · Lipids in Health and Disease
Apolipoprotein A (ApoA) in Neurological Disorders: Connections and Insights
Humam Emad Rajha, Ahmed Hassanein, Rowan Mesilhy, Zainab Nurulhaque, Nebras Elghoul, Patrick G. Burgon, Rafif Mahmood Al Saady, Shona Pedersen · 2025 · International Journal of Molecular Sciences
Managing dyslipidaemia in type 2 diabetes mellitus
Auryan Szalat, Ronen Y. Durst, Eran Leitersdorf · 2016 · Best Practice & Research Clinical Endocrinology & Metabolism
Synchrotron radiation circular dichroism spectroscopy reveals structural divergences in HDL-bound apoA-I variants
Rita Del Giudice, Oktawia Nilsson, Joan Domingo‐Espín, Jens O. Lagerstedt · 2017 · Scientific Reports
Peptide-based high-density lipoprotein promotes adipose tissue browning and restrains development of atherosclerosis and type 2 diabetes
Ruodan Xu, Shizhong Li, Mingfei Shi, Ziyun Li, Yin Wang, Jing Li, Qiang Li, Lasse Hyldgaard Klausen, An Li, Haiyu Zhao et al. · 2020 · Nano Today
Link Between ER-Stress, PPAR-Alpha Activation, and BET Inhibition in Relation to Apolipoprotein A-I Transcription in HepG2 Cells
Sophie E. van der Krieken, Herman E. Popeijus, Ronald P. Mensink, Jogchum Plat · 2016 · Journal of Cellular Biochemistry
Liver X receptors: From pharmacology to nanoparticle-based drug delivery
Hua, Xiaofen, Wei, Xiduan · 2023 · European Journal of Pharmacology
Probing the Effect of Bioinspired Nanomaterials on Angiogenic Sprouting With a Microengineered Vascular System
Ahn, Jungho, Sei, Yoshitaka J., Jeon, Noo Li, Kim, YongTae · 2018 · IEEE Transactions on Nanotechnology
Apolipoproteins as context-dependent regulators of lung inflammation
Debbie M Figueroa, Elizabeth M. Gordon, Xianglan Yao, Stewart J. Levine · 2018 · Elsevier eBooks
Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein
Zelong Jin, Zhou Lan, Rong Tian, Naihao Lu · 2021 · Chemical Research in Toxicology
HDL-Chitosan Nanoparticles for siRNA Delivery as an SR-B1 Receptor Targeted System
Rasim Masimov, Gülay Büyükköroğlu · 2023 · Combinatorial Chemistry & High Throughput Screening
High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease
Huihui Liu, Yuan‐Lin Guo, Na‐Qiong Wu, Cheng‐Gang Zhu, Ying Gao, Ping Qing, Sha Li, Xi Zhao, Yan Zhang, Di Sun et al. · 2017 · Atherosclerosis
Novel Approaches for HDL-Directed Therapies
Jacques J. Genest, Hong Y. Choi · 2017 · Current Atherosclerosis Reports
Psoriasis comorbid with atherosclerosis meets in lipid metabolism
Liuping Chen, Huiqi Chen, Sien Guo, Zhijun Chen, Haifeng Yang, Yanjiao Liu, Xiaoling Chen, Xinming Chen, Tingting Du, Xinyao Long et al. · 2023 · Frontiers in Pharmacology
The Human Gut and Dietary Salt: The Bacteroides/Prevotella Ratio as a Potential Marker of Sodium Intake and Beyond
Omololu Fagunwa, Kirsty Davies, Jane Bradbury · 2024 · Nutrients
Comment on “Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice” by Rebholz S.L. et al. Toxicol. Rep. 2016 (3) 46–54
Hans M. G. Princen, Marianne G. Pouwer, Elsbet Jantine Pieterman · 2016 · Toxicology Reports
Future Lipid-Altering Therapeutic Options Targeting Residual Cardiovascular Risk
Michel Farnier · 2016 · Current Cardiology Reports